EUVIMEDEUVIMED entdecken
Crossref

Prognostic Value of Baseline Metabolic Tumor Volume on [18F]FDG PET/CT in Metastatic Breast Cancer Treated With CDK4/6 Inhibitors

Seyma Erdogan, Yusufcan Yılmaz, Elif Reyhan Aslan, Refia Yukselturk, Efnan Algın, Berna Okudan, Osman Inan, Oznur Bal

Clinical Breast Cancer · 2026-11 · 26 (11) · 25-31

DOI: 10.1016/j.clbc.2026.09.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Breast Cancer, 2026-11. Verfasst von Seyma Erdogan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Health Science University, Ankara City Hospital, Ankara, Turkey. Electronic address: seymaerdgn35@gmail.com. Hauptthemen laut MEDLINE: Breast Neoplasms, Cyclin-Dependent Kinase 4, Positron Emission Tomography Computed Tomography, Cyclin-Dependent Kinase 6. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCyclin-Dependent Kinase 4Positron Emission Tomography Computed TomographyCyclin-Dependent Kinase 6Protein Kinase InhibitorsHumansFemaleRetrospective StudiesFluorodeoxyglucose F18PrognosisMiddle AgedAgedTumor BurdenPyridinesAminopyridinesPiperazinesAdultPurinesRadiopharmaceuticalsProgression-Free Survival

Stichwörter der Autor:innen

Cyclin-dependent kinase 4/6 inhibitorsOverall survivalProgression-free survivalTotal metabolic tumor volume

Substanzen

Fluorodeoxyglucose F18Cyclin-Dependent Kinase 4Cyclin-Dependent Kinase 6Protein Kinase InhibitorspalbociclibribociclibPyridinesAminopyridinesPiperazinesCDK4 protein, human

Autor:innen und Institutionen

  • Department of Internal Medicine, Health Science University, Ankara City Hospital, Ankara, Turkey. Electronic address: seymaerdgn35@gmail.com.
  • Department of Internal Medicine, Health Science University, Ankara City Hospital, Ankara, Turkey.
  • Department of Nuclear Medicine, Health Science University, Ankara City Hospital, Ankara, Turkey.
  • Department of Medical Oncology, Health Science University, Ankara City Hospital, Ankara, Turkey.

Zitieren

APA

Erdogan, S., Yılmaz, Y., Aslan, E. R., Yukselturk, R., Algın, E., Okudan, B., Inan, O., & Bal, O. (2026). Prognostic Value of Baseline Metabolic Tumor Volume on [18F]FDG PET/CT in Metastatic Breast Cancer Treated With CDK4/6 Inhibitors. Clinical Breast Cancer, 26(11), 25-31. https://doi.org/10.1016/j.clbc.2026.09.009

Vancouver

Erdogan S, Yılmaz Y, Aslan ER, Yukselturk R, Algın E, Okudan B, et al. Prognostic Value of Baseline Metabolic Tumor Volume on [18F]FDG PET/CT in Metastatic Breast Cancer Treated With CDK4/6 Inhibitors. Clinical Breast Cancer. 2026;26(11):25-31. doi:10.1016/j.clbc.2026.09.009

BibTeX
@article{Erdogan2026,
  author = {Erdogan, Seyma and Yılmaz, Yusufcan and Aslan, Elif Reyhan and Yukselturk, Refia and Algın, Efnan and Okudan, Berna and Inan, Osman and Bal, Oznur},
  title = {Prognostic Value of Baseline Metabolic Tumor Volume on [18F]FDG PET/CT in Metastatic Breast Cancer Treated With CDK4/6 Inhibitors},
  journal = {Clinical Breast Cancer},
  year = {2026},
  volume = {26},
  number = {11},
  pages = {25--31},
  doi = {10.1016/j.clbc.2026.09.009}
}
Kostenlos starten →